ISMP alerts providers to drug mix-up danger due to packaging
The Institute for Safe Medication Practices is alerting hospitals, ambulatory surgical centers and anesthesia professionals about the potential for dangerous mix-ups due to look-alike packaging for the drugs Bloxiverz (neostigmine) and Vazculep (phenylephrine) made by Eclat Pharmaceuticals. In the past three months, ISMP’s National Medication Errors Reporting Program has received eight practitioner reports expressing concern about the packaging. To prevent mix-ups, ISMP recommends keeping supplies of the drugs widely separated, alerting staff to the potential risk of confusion, and verifying product selection, among other actions.
Related News Articles
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
The Centers for Medicare & Medicaid Services should continue to work with national standards body X12 to include the new unique device identifier on its…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Sept. 30 to review their 2016 quality data before it is publicly reported on the…
Headline
The Institute for Safe Medication Practices yesterday released a tool to help hospitals and outpatient facilities evaluate their safety practices for “…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 20 on a “new direction” for its Innovation Center that will approach…